Advertisement
Organisation › Details
Medtech Accelerator (GB, HEE NHS et al.)
The Medtech Accelerator, a new proof of concept financial awards scheme to progress medical technology and software innovations developed primarily from within the NHS, launches today. With awards on offer between £15K and £125K, this new joint venture brings together the NHS, local authority and local business. Supporting NHS innovation with early stage proof of concept awards The Medtech Accelerator will support and finance development projects at an early stage to maximise the potential for success in bringing new life enhancing technologies to patients. Awards are available to NHS organisations with a total of £1.5 million on offer for innovations that show the greatest promise, with the potential to create future spin-out companies. Awards are aimed at supporting proof of concept work which typically includes market research, product and market validation, prototype development and testing, and IP protection. Led by Health Enterprise East (HEE), a leading NHS innovation hub, the initiative includes New Anglia Capital Ltd, a subsidiary of New Anglia Local Enterprise Partnerships (LEP), Greater Cambridge & Greater Peterborough (GCGP) LEP, and the Eastern AHSN. LEPs and Eastern AHSN have each invested £500K and will have access to HEE’s expertise in proof of concept and technology transfer and to its existing pipeline of NHS technologies through its membership base, including internationally renowned centres of healthcare research and innovation. *
Start | 2016-11-23 established jv | |
Group | United Kingdom (GB) (govt) | |
Industry | finance | |
Industry 2 | MedTech (medical technology) | |
Person | Blackwood, Anne (United Kingdom (govt) 201607 CEO at HEE) | |
Region | United Kingdom (GB) | |
City | n. a. | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: | ||
Record changed: 2023-07-10 |
Advertisement
More documents for United Kingdom (GB) (govt)
- [1] Earlybird VC Management GmbH & Co KG. (2/14/24). "Press Release: Earlybird Health Closes Fresh Fund of EUR 173m". Berlin & Cologne....
- [2] UK Government (Dept. for Science, Innovation and Technology). (12/5/23). "Press Release: Government Publishes £2 Billion Vision for Engineering Biology to Revolutionise Medicine, Food and Environmental Protection"....
- [3] Cresset Biomolecular Discovery Ltd.. (10/18/23). "Press Release: Cresset Targets International Growth with Innovate UK Scaleup Programme". Cambridge....
- [4] Exscientia plc. (10/17/23). "Press Release: Parker Moss to Join Exscientia as EVP, Corporate Development". Oxford....
- [5] Medicines Discovery Catapult (MDC). (10/5/23). "Press Release: UK Launches Its First National Total-body PET Platform for Drug Discovery"....
- [6] NK:IO Ltd.. (7/11/23). "Press Release: Imperial Spinout NK:IO Awarded £1.6M Innovate UK New Cancer Therapeutics Grant for Development of Pioneering NK Cell Therapy". London....
- [7] BioNTech SE. (1/6/23). "Press Release: BioNTech Announces Strategic Partnership with UK Government to Provide up to 10,000 Patients with Personalized mRNA Cancer Immunotherapies by 2030". Mainz....
- [8] Medicines Discovery Catapult (MDC). (10/26/22). "Press Release: Medicines Discovery Catapult Appoints International Entrepreneur Volker Hirsch to Bolster Commercial Expertise"....
- [9] Medicines Discovery Catapult (MDC). (8/11/22). "Press Release: Medicines Discovery Catapult and Zeiss Set Sights on Advancing Microscopy. Driving the Application of Microscopy in Drug Discovery"....
- [10] Francis Crick Institute Ltd., The. (7/11/22). "Press Release: £1billion Invested in the Future of UK Discovery Science"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top